World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
64
Citations
12905
World Ranking
8136
National Ranking
11

Kelly Chibale publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Kelly Chibale sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 367 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Kelly Chibale D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kelly Chibale sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 64 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa

Overview

Kelly Chibale is affiliated with the University of Cape Town in South Africa and conducts research primarily in the field of medicine. Their work focuses extensively on infectious diseases and public health, with particular emphasis on malaria research and control as well as computational drug discovery methods.

The scientist has published numerous papers covering a range of topics related to infectious diseases, including malaria, leishmaniasis, tuberculosis, and HIV/AIDS drug development. Their research also extends to cancer therapeutics and mosquito-borne diseases. Key areas of study include:

  • Malaria Research and Control
  • Research on Leishmaniasis Studies
  • Computational Drug Discovery Methods
  • Tuberculosis Research and Epidemiology
  • HIV/AIDS drug development and treatment
  • Cancer therapeutics and mechanisms
  • Mosquito-borne diseases and control

Chibale's subfields of study highlight a multidisciplinary approach incorporating molecular biology, organic chemistry, computational theory and mathematics, and public health. The most frequent publication venues for their work include:

  • ACS Infectious Diseases
  • Journal of Medicinal Chemistry
  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Trends in Parasitology

Frequent coauthors collaborating with Kelly Chibale include Janette Reader, Mariëtte van der Watt, Lyn-Marié Birkholtz, Mathew Njoroge, and Dale Taylor.

Recent notable papers authored or coauthored by Kelly Chibale include:

  • Antiviral drug discovery: preparing for the next pandemic (2021, Chemical Society Reviews)
  • MalDA, Accelerating Malaria Drug Discovery (2021, Trends in Parasitology)
  • Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box (2021, Nature Communications)
  • Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity (2020, Cell chemical biology)
  • Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities (2021, ACS Infectious Diseases)

Kelly Chibale has received recognition in the form of an appointment as Fellow of the Royal Society of South Africa.

Best Publications

  • Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds

    Eric M. Guantai;Kanyile Ncokazi;Timothy J. Egan;Jiri Gut

  • Exploring the potential of xanthene derivatives as trypanothione reductase inhibitors and chloroquine potentiating agents

    Kelly Chibale;Mark Visser;Donelly van Schalkwyk;Peter J Smith

  • Antiviral drug discovery: preparing for the next pandemic.

    Catherine S Adamson;Kelly Chibale;Rebecca J M Goss;Marcel Jaspars

  • Synthesis, antimalarial and antitubercular activity of acetylenic chalcones

    Renate H. Hans;Eric M. Guantai;Carmen Lategan;Peter J. Smith

  • Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives

    Idan Chiyanzu;Cailean Clarkson;Peter J. Smith;Julie Lehman

  • Strategies to Combat Multi-Drug Resistance in Tuberculosis.

    Vinayak Singh;Vinayak Singh;Kelly Chibale;Kelly Chibale

  • The state of the art in anti-malarial drug discovery and development.

    Jeremy N. Burrows;Kelly Chibale;Timothy N.C. Wells

  • Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain.

    Idan Chiyanzu;Elizabeth Hansell;Jiri Gut;Philip J. Rosenthal

  • Antimalarial drug discovery: progress and approaches

    Unknown

  • 3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential

    Yassir Younis;Frederic Douelle;Tzu-Shean Feng;Diego Gonzalez Cabrera

  • Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery.

    Moses Hohman;Kellan Gregory;Kelly Chibale;Peter J. Smith

  • Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine

    Kelly Chibale;Hayley Haupt;Howard Kendrick;Vanessa Yardley

  • Synthesis and antiplasmodial activity in vitro of new ferrocene–chloroquine analogues

    Paul Beagley;Margaret A. L. Blackie;Kelly Chibale;Cailean Clarkson

  • Recent approaches to chemical discovery and development against malaria and the neglected tropical diseases human African trypanosomiasis and schistosomiasis.

    Mathew Njoroge;Nicholas M. Njuguna;Peggoty Mutai;Dennis S. B. Ongarora

  • Antimalarial Pyrido[1,2-a]benzimidazoles

    Albert J. Ndakala;Richard K. Gessner;Patricia W. Gitari;Natasha October

  • UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.

    Christel Brunschwig;Nina Lawrence;Dale Taylor;Efrem Abay

  • Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies.

    Kamaljit Singh;Hardeep Kaur;Peter Smith;Carmen de Kock

  • Cyclopalladated complexes containing tridentate thiosemicarbazone ligands of biological significance: Synthesis, structure and antimalarial activity

    Prinessa Chellan;Shereen Nasser;Livia Vivas;Kelly Chibale

  • Design, synthesis and biological evaluation of carbohydrate-based mimetics of cRGDFV

    K.C. Nicolaou;K.C. Nicolaou;John I. Trujillo;John I. Trujillo;Kelly Chibale;Kelly Chibale

  • Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studies.

    Eric M. Guantai;Kanyile Ncokazi;Timothy J. Egan;Jiri Gut

  • The synthesis and antiparasitic activity of aryl- and ferrocenyl-derived thiosemicarbazone ruthenium(II)-arene complexes.

    Muneebah Adams;Yiqun Li;Heena Khot;Carmen De Kock

  • New amine and urea analogs of ferrochloroquine: synthesis, antimalarial activity in vitro and electrochemical studies

    Kelly Chibale;John R Moss;Margaret Blackie;Donelly van Schalkwyk

Frequent Co-Authors

Peter Smith
Peter Smith University of Aberdeen
Sergio Wittlin
Sergio Wittlin Swiss Tropical and Public Health Institute
Philip J. Rosenthal
Philip J. Rosenthal University of California, San Francisco
Jiri Gut
Jiri Gut University of California, San Francisco
Timothy J. Egan
Timothy J. Egan University of Cape Town
Susan A. Charman
Susan A. Charman Monash University
Vanessa Yardley
Vanessa Yardley London School of Hygiene & Tropical Medicine
Norbert De Kimpe
Norbert De Kimpe Ghent University
K. C. Nicolaou
K. C. Nicolaou Rice University
Elizabeth A. Winzeler
Elizabeth A. Winzeler University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in pursuing Chemistry in the USA, several related career paths offer specialized opportunities. For instance, becoming a pharmacist requires a strong foundation in chemistry and biology. To learn more about the steps involved, you can explore how do you become a pharmacist, which outlines the education and licensing needed for this rewarding healthcare role.

Another intriguing career linking chemistry and forensic science is that of an autopsy technician. These professionals assist in determining causes of death using scientific methods. Understanding how much do autopsy techs make can provide insight into the financial and professional outlook of this vital job.

For those looking to study forensic science affordably, there are programs available that balance quality with cost. Checking out the cheapest online forensic science degree options can help prospective students find suitable programs that fit their budgets while providing the necessary expertise.

Additionally, expanding into forensic psychology at the graduate level offers a unique blend of psychology and forensic science. An online masters forensic psychology degree allows students to deepen their understanding of criminal behavior and mental health in legal contexts, often with flexible learning schedules.

Exploring these related fields and programs can open new educational and career pathways that complement a foundation in chemistry and satisfy diverse professional goals.

Best Scientists Citing Kelly Chibale

Trending Scientists

Recently Published Articles